Related Experiment Video
Updated: Jun 17, 2025

10:38
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
20.2K
A Case of Atypical Scleroderma Renal Crisis
Ayushi Lalwani1, Shefali Amin1, Zohaib Yousaf1
1Department of Internal Medicine, Reading Hospital, West Reading USA.
European Journal of Case Reports in Internal Medicine
|August 12, 2024
Summary
This case study emphasizes diagnosing scleroderma renal crisis (SRC) in systemic sclerosis (SSc) patients. Early clinical judgment and diagnostic tools are crucial, especially when serology is non-specific.
Area of Science:
- Rheumatology
- Nephrology
- Pulmonology
Background:
- Scleroderma renal crisis (SRC) is a significant complication of systemic sclerosis (SSc).
- Early diagnosis is vital for managing morbidity and mortality associated with SRC.
- Atypical presentations can challenge timely diagnosis.
Purpose of the Study:
- To highlight a case of atypical systemic sclerosis (SSc) presenting with acute scleroderma renal crisis (SRC).
- To emphasize the importance of clinical acumen in diagnosing SRC when serological markers are non-specific.
- To underscore the utility of diagnostic tools beyond laboratory tests.
Main Methods:
- Case report of a 63-year-old female with progressive dyspnea.
- Evaluation of restrictive lung pathology and worsening renal function.
- Renal biopsy for diagnosis confirmation.
- Treatment initiated with captopril.
Main Results:
- Diagnosis of atypical systemic sclerosis (SSc) in the context of acute scleroderma renal crisis (SRC).
- Renal biopsy confirmed scleroderma renal disease.
- Patient received captopril treatment.
Conclusions:
- Scleroderma renal crisis (SRC) is a critical concern in systemic sclerosis (SSc) management.
- Clinicians must maintain a high index of suspicion for SRC.
- Diagnosis often relies on clinical findings and investigations like imaging and biopsies due to non-specific serologies.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Dialysis
281
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
281

